← Open Payments lookup

KELLY BATTEN: Open Payments

NPI 1902464977 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,127 in 58 payments from 15 companies in 2025. Trend: 2023 $1,067 · 2024 $1,345 · 2025 $1,127

Food & beverage: $1,127
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.7$227
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$226
Otsuka America Pharmaceutical, Inc.11$158
Neurocrine BioSciences, Inc.5$98
ABBVIE INC.4$69
Janssen Pharmaceuticals, Inc3$64
Axsome Therapeutics, Inc.3$63
Teva Pharmaceuticals USA, Inc.3$46
Takeda Pharmaceuticals U.S.A., Inc.2$36
E.R. Squibb & Sons, L.L.C.2$35

Products named: CAPLYTA, REXULTI, FANAPT, HETLIOZ, INGREZZA, VRAYLAR, SPRAVATO, Auvelity.

Industry payments across IN — which companies pay providers there.